Titre : Galactose

Galactose : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cell Engineering
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Galactose : Questions médicales les plus fréquentes", "headline": "Galactose : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Galactose : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-04", "dateModified": "2025-03-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Galactose" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hexose", "url": "https://questionsmedicales.fr/mesh/D006601", "about": { "@type": "MedicalCondition", "name": "Hexose", "code": { "@type": "MedicalCode", "code": "D006601", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D09.947.875.359" } } }, "about": { "@type": "MedicalCondition", "name": "Galactose", "alternateName": "Galactose", "code": { "@type": "MedicalCode", "code": "D005690", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Tilo Biedermann", "url": "https://questionsmedicales.fr/author/Tilo%20Biedermann", "affiliation": { "@type": "Organization", "name": "Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany." } }, { "@type": "Person", "name": "Eva Morava", "url": "https://questionsmedicales.fr/author/Eva%20Morava", "affiliation": { "@type": "Organization", "name": "Department of Paediatrics and Metabolic Center, University Hospitals Leuven, Leuven, Belgium. peter.witters@uzleuven.be." } }, { "@type": "Person", "name": "Scott P Commins", "url": "https://questionsmedicales.fr/author/Scott%20P%20Commins", "affiliation": { "@type": "Organization", "name": "Division of Rheumatology, Allergy, and Immunology, University of North Carolina, Chapel Hill, North Carolina." } }, { "@type": "Person", "name": "Marianne van Hage", "url": "https://questionsmedicales.fr/author/Marianne%20van%20Hage", "affiliation": { "@type": "Organization", "name": "Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet and University Hospital, Stockholm, Sweden." } }, { "@type": "Person", "name": "Michael Levin", "url": "https://questionsmedicales.fr/author/Michael%20Levin", "affiliation": { "@type": "Organization", "name": "Division of Paediatric Allergy, University of Cape Town, Cape Town, South Africa. Electronic address: Michael.levin@uct.ac.za." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Interfacial Engineering Enables Perovskite Heteroepitaxial Growth on Black Phosphorus for Flexible X-ray Detectors.", "datePublished": "2023-07-20", "url": "https://questionsmedicales.fr/article/37475501", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/smll.202303229" } }, { "@type": "ScholarlyArticle", "name": "Reversing the Enantioselectivity of Enzymatic Carbene N-H Insertion Through Mechanism-Guided Protein Engineering.", "datePublished": "2023-07-20", "url": "https://questionsmedicales.fr/article/37260412", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/anie.202303879" } }, { "@type": "ScholarlyArticle", "name": "Reverse engineering DNA origami nanostructure designs from raw scaffold and staple sequence lists.", "datePublished": "2023-07-16", "url": "https://questionsmedicales.fr/article/37520280", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.csbj.2023.07.011" } }, { "@type": "ScholarlyArticle", "name": "Graft dysfunction in compassionate use of genetically engineered pig-to-human cardiac xenotransplantation: a case report.", "datePublished": "2023-06-29", "url": "https://questionsmedicales.fr/article/37393920", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/S0140-6736(23)00775-4" } }, { "@type": "ScholarlyArticle", "name": "MXene functionalized collagen biomaterials for cardiac tissue engineering driving iPSC-derived cardiomyocyte maturation.", "datePublished": "2023-06-27", "url": "https://questionsmedicales.fr/article/38665478", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41699-023-00409-w" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Glucides", "item": "https://questionsmedicales.fr/mesh/D002241" }, { "@type": "ListItem", "position": 3, "name": "Sucres", "item": "https://questionsmedicales.fr/mesh/D000073893" }, { "@type": "ListItem", "position": 4, "name": "Oses", "item": "https://questionsmedicales.fr/mesh/D009005" }, { "@type": "ListItem", "position": 5, "name": "Hexose", "item": "https://questionsmedicales.fr/mesh/D006601" }, { "@type": "ListItem", "position": 6, "name": "Galactose", "item": "https://questionsmedicales.fr/mesh/D005690" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Galactose - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Galactose", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Galactose", "description": "Comment diagnostiquer une intolérance à la galactose ?\nQuels tests sont utilisés pour détecter la galactosémie ?\nQuels symptômes indiquent un problème avec la galactose ?\nComment évaluer le métabolisme de la galactose ?\nQuel rôle joue l'enzyme galactose-1-phosphate uridyltransférase ?", "url": "https://questionsmedicales.fr/mesh/D005690?mesh_terms=Cell+Engineering&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Galactose", "description": "Quels sont les symptômes d'une galactosémie ?\nComment se manifeste l'intolérance au galactose ?\nQuels signes indiquent une surcharge de galactose ?\nLa galactose peut-elle causer des problèmes oculaires ?\nQuels symptômes neurologiques sont associés à la galactosémie ?", "url": "https://questionsmedicales.fr/mesh/D005690?mesh_terms=Cell+Engineering&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Galactose", "description": "Comment prévenir la galactosémie chez les nouveau-nés ?\nLes femmes enceintes doivent-elles se soucier de la galactose ?\nQuels aliments éviter pour prévenir l'intolérance au galactose ?\nLe dépistage génétique est-il utile pour la galactosémie ?\nComment sensibiliser à la galactosémie ?", "url": "https://questionsmedicales.fr/mesh/D005690?mesh_terms=Cell+Engineering&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Galactose", "description": "Quel est le traitement principal de la galactosémie ?\nPeut-on utiliser des suppléments pour la galactosémie ?\nComment gérer l'intolérance au galactose ?\nY a-t-il des médicaments pour traiter la galactosémie ?\nComment surveiller l'évolution d'une galactosémie ?", "url": "https://questionsmedicales.fr/mesh/D005690?mesh_terms=Cell+Engineering&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Galactose", "description": "Quelles complications peuvent survenir avec la galactosémie ?\nLa galactosémie peut-elle affecter le développement physique ?\nQuels risques neurologiques sont associés à la galactosémie ?\nComment la galactosémie affecte-t-elle le foie ?\nY a-t-il des complications à long terme de la galactosémie ?", "url": "https://questionsmedicales.fr/mesh/D005690?mesh_terms=Cell+Engineering&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Galactose", "description": "Quels sont les facteurs de risque de la galactosémie ?\nLa consanguinité augmente-t-elle le risque de galactosémie ?\nLes femmes porteuses de gènes de galactosémie doivent-elles s'inquiéter ?\nLes populations spécifiques sont-elles plus à risque ?\nComment les tests génétiques aident-ils à évaluer le risque ?", "url": "https://questionsmedicales.fr/mesh/D005690?mesh_terms=Cell+Engineering&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intolérance à la galactose ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un test de tolérance au galactose et des analyses sanguines peuvent confirmer l'intolérance." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter la galactosémie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques et des dosages de galactose dans le sang sont utilisés." } }, { "@type": "Question", "name": "Quels symptômes indiquent un problème avec la galactose ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la diarrhée, les vomissements et la jaunisse peuvent indiquer un problème." } }, { "@type": "Question", "name": "Comment évaluer le métabolisme de la galactose ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de métabolisme et des analyses enzymatiques peuvent évaluer la dégradation de la galactose." } }, { "@type": "Question", "name": "Quel rôle joue l'enzyme galactose-1-phosphate uridyltransférase ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Cette enzyme est cruciale pour le métabolisme de la galactose et son absence cause des troubles." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une galactosémie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent vomissements, diarrhée, jaunisse et retard de croissance." } }, { "@type": "Question", "name": "Comment se manifeste l'intolérance au galactose ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle se manifeste par des douleurs abdominales, des ballonnements et des diarrhées après ingestion." } }, { "@type": "Question", "name": "Quels signes indiquent une surcharge de galactose ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme la fatigue, des troubles neurologiques et des problèmes hépatiques peuvent apparaître." } }, { "@type": "Question", "name": "La galactose peut-elle causer des problèmes oculaires ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une accumulation de galactose peut entraîner des cataractes et d'autres problèmes oculaires." } }, { "@type": "Question", "name": "Quels symptômes neurologiques sont associés à la galactosémie ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles du développement, des convulsions et des retards mentaux peuvent survenir." } }, { "@type": "Question", "name": "Comment prévenir la galactosémie chez les nouveau-nés ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Le dépistage néonatal permet de détecter la galactosémie et d'initier un traitement précoce." } }, { "@type": "Question", "name": "Les femmes enceintes doivent-elles se soucier de la galactose ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles doivent surveiller leur consommation de galactose, surtout si des antécédents familiaux existent." } }, { "@type": "Question", "name": "Quels aliments éviter pour prévenir l'intolérance au galactose ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les produits laitiers, les légumineuses et certains fruits comme les cerises." } }, { "@type": "Question", "name": "Le dépistage génétique est-il utile pour la galactosémie ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut identifier les porteurs et les personnes à risque de développer la maladie." } }, { "@type": "Question", "name": "Comment sensibiliser à la galactosémie ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des campagnes d'information et des ressources éducatives peuvent aider à sensibiliser le public." } }, { "@type": "Question", "name": "Quel est le traitement principal de la galactosémie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement consiste à suivre un régime strict sans galactose, excluant les produits laitiers." } }, { "@type": "Question", "name": "Peut-on utiliser des suppléments pour la galactosémie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments de calcium et de vitamine D peuvent être nécessaires en raison d'un régime restrictif." } }, { "@type": "Question", "name": "Comment gérer l'intolérance au galactose ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les aliments contenant du galactose et consulter un diététicien pour un suivi." } }, { "@type": "Question", "name": "Y a-t-il des médicaments pour traiter la galactosémie ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de médicaments spécifiques, le régime est le traitement principal." } }, { "@type": "Question", "name": "Comment surveiller l'évolution d'une galactosémie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des contrôles réguliers des niveaux de galactose et des évaluations cliniques sont nécessaires." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec la galactosémie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des problèmes hépatiques, des cataractes et des troubles neurologiques." } }, { "@type": "Question", "name": "La galactosémie peut-elle affecter le développement physique ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner un retard de croissance et des problèmes de développement physique." } }, { "@type": "Question", "name": "Quels risques neurologiques sont associés à la galactosémie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des convulsions, des retards mentaux et des troubles du comportement peuvent survenir." } }, { "@type": "Question", "name": "Comment la galactosémie affecte-t-elle le foie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut provoquer une hépatomégalie et des lésions hépatiques dues à l'accumulation de galactose." } }, { "@type": "Question", "name": "Y a-t-il des complications à long terme de la galactosémie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications à long terme incluent des troubles cognitifs et des problèmes de vision." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de la galactosémie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux de galactosémie et certaines mutations génétiques augmentent le risque." } }, { "@type": "Question", "name": "La consanguinité augmente-t-elle le risque de galactosémie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la consanguinité peut augmenter le risque de transmission de la galactosémie." } }, { "@type": "Question", "name": "Les femmes porteuses de gènes de galactosémie doivent-elles s'inquiéter ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent transmettre le gène à leurs enfants, augmentant le risque de la maladie." } }, { "@type": "Question", "name": "Les populations spécifiques sont-elles plus à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines populations, comme les Ashkénazes, ont un risque plus élevé de galactosémie." } }, { "@type": "Question", "name": "Comment les tests génétiques aident-ils à évaluer le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les tests génétiques peuvent identifier les porteurs et évaluer le risque de transmission." } } ] } ] }

Sources (10000 au total)

Graft dysfunction in compassionate use of genetically engineered pig-to-human cardiac xenotransplantation: a case report.

A genetically engineered pig cardiac xenotransplantation was done on Jan 7, 2022, in a non-ambulatory male patient, aged 57 years, with end-stage heart failure, and on veno-arterial extracorporeal mem... Physiological and biochemical parameters critical for the care of all heart transplant recipients were collected in extensive clinical monitoring in an intensive care unit. To ascertain the cause of x... After successful xenotransplantation, the graft functioned well on echocardiography and sustained cardiovascular and other organ systems functions until postoperative day 47 when diastolic heart failu... Hyperacute rejection was avoided. We identified potential mediators of the observed endothelial injury. First, widespread endothelial injury indicates antibody-mediated rejection. Second, IVIG bound s... The University of Maryland School of Medicine, and the University of Maryland Medical Center....

Autologous Skin Grafts, versus Tissue-engineered Skin Constructs: A Systematic Review and Meta-analysis.

For over 100 years, autologous skin grafts have remained the gold standard for the reconstruction of wounds but are limited in availability. Acellular tissue-engineered skin constructs (acellular TCs)... A systematic review was conducted using PRISMA guidelines, querying MEDLINE, Embase, Web of Science, and Cochrane to assess graft incorporation, failure, and wound healing. Case reports/series, review... Sixty-six articles encompassing 4076 patients were included. No significant differences were found between graft failure rates (P = 0.07) and mean difference of percent reepithelialization (p = 0.92) ... This systematic review is the first to illustrate comparable functional and wound healing outcomes between split-thickness skin grafts alone and those co-grafted with acellular TCs. The use of cellula...

Cellular composition modifies the biological properties and stability of platelet rich plasma membranes for tissue engineering.

Scaffolds should provide structural support for tissue regeneration, allowing their gradual biodegradation and interacting with cells and bioactive molecules to promote remodeling. Thus, the scaffold'...

Preparation and evaluation of a polycaprolactone/chitosan/propolis fibrous nanocomposite scaffold as a tissue engineering skin substitute.

Recently, the application of nanofibrous mats for dressing skin wounds has received great attention. In this study, we aimed to fabricate and characterize an electrospun nanofibrous mat containing pol... Raw propolis was extracted, and its phenolic and flavonoid contents were measured. The physiochemical and biological properties of the fabricated mats, including PCL, PCL/CTS, and PCL/CTS/Propolis wer... The results revealed that the propolis extract contained high amounts of phenolic and flavonoid compounds. The fabricated scaffold had suitable physicochemical and mechanical properties. Uniform, bead... The nanofibrous PCL/CTS/Propolis mat can be applied as a tissue-engineered skin substitute for healing cutaneous wounds, such as burn wounds....